InvestSMART

Avecho Biotechnology Limited (ASX:AVE)

ALERT: Price-sensitive ASX Announcement for AVE
Current share price for AVE : $0.022 0.007 (46.67%)+
Announcement
Release
22 Jun 2026 8:31AM
Price at Release
$0.015
Full Release
download
Summary
Avecho Biotechnology Limited (ASX: AVE) has requested a trading halt of its securities on the Australian Securities Exchange. The halt is requested to manage the company's continuous disclosure obligations as it prepares to announce the outcome of the interim analysis of its Phase III trial for its proprietary cannabidiol (CBD) TPM capsule designed for insomnia. The halt will remain in effect until the earlier of normal trading commencement on 24 June 2026 or the release of the announcement.
Key Points
  • Avecho Biotechnology Limited requests a trading halt
  • The trading halt is pending an announcement on Phase III trial results
  • The securities will remain halted until 24 June 2026 or until the announcement is made
  • The trading halt is necessary for continuous disclosure obligations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.